Matthew T. Mullarkey
2009
Compensation breakdown
| Bonus | $35,417 |
|---|---|
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $22,355 |
| Non-Equity Incentive Plan | $281,376 |
| Option Awards | $147,200 |
| Salary | $394,615 |
| Stock Awards | $401,125 |
| Other | $159,296 |
| Total | $1,441,384 |
Mullarkey received $401.1K in stock awards, accounting for 28% of the total pay in 2009.
Mullarkey also received $35.4K in bonus, $22.4K of change in pension value and nonqualified deferred compensation earnings, $281.4K in non-equity incentive plan, $147.2K in option awards, $394.6K in salary and $159.3K in other compensation.
Rankings
In 2009, Matthew T. Mullarkey's compensation ranked 3,313th out of 9,885 executives tracked by ExecPay. In other words, Mullarkey earned more than 66.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,313 out of 9,885 | 67th |
Division Manufacturing | 1,159 out of 3,690 | 69th |
Major group Rubber And Miscellaneous Plastics Products | 39 out of 84 | 54th |
Industry group Fabricated Rubber Products, Not Elsewhere | 7 out of 21 | 67th |
Mullarkey's colleagues
We found five more compensation records of executives who worked with Matthew T. Mullarkey at West Pharmaceutical Services in 2009.
2009
Donald Morel
West Pharmaceutical Services
Chief Executive Officer
2009
Steven Ellers
West Pharmaceutical Services
Chief Operating Officer
2009
William Federici
West Pharmaceutical Services
Chief Financial Officer
2009
John Gailey
West Pharmaceutical Services
General Counsel
2009
Heino Lennartz
West Pharmaceutical Services